Efficacy and Safety of FTY720 for Acute Stroke

Recruiting

Phase 2 Results N/A

Summary of Purpose

Stroke is one of the main severe disease of public health importance. Increasing evidence suggests that inflammatory mechanisms plays a significant role in stroke. So, immune targets are supposed to be an effective one. The sphingosine-1-phosphate receptor regulator Fingolimod(FTY720)is an effective immunology modulator which has been widely used in autoimmune disease and has been testified effective on stoke...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 September 2014.

1 Oct 2012 24 Nov 2013 1 Oct 2014 1 Oct 2014 1 Sep 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts